12/06/2025
🏔️ APEX 7 eQTL 🏔️
APEX 7 eQTL will investigate expression quantitative trait loci (eQTLs) in hypobaric hypoxia. This research element is led by Anya (head of research) and supervised by Professor Kenneth Baillie (The University of Edinburgh).
Prof Baillie led the very first APEX expedition in 2001, and founded the APEX Charity. He is Chief Investigator of the APEX 7 Study, and has contributed greatly to all APEX expeditions through providing mentorship and support. He works as a consultant in the intensive care unit at the Royal Infirmary of Edinburgh, and is Co-Director of the Pandemic Science Hub. During the Covid outbreak in 2020-2021, he led the UK-wide GenOMICC and ISARIC4C studies, and contributed to the design and delivery of the RECOVERY trial. He discovered new biological mechanisms underlying critical illness in Covid, and contributed to the discovery of effective drug treatments to reduce mortality.
Prof Baillie leads a research programme in translational genomics- using genetic signals from critically ill patients to identify both the targets for drug therapy, and the groups of patients likely to benefit most from any treatment, and testing those therapeutic ideas in highly-efficient model systems.
APEX 7 eQTL will be a continuation of work from previous expeditions: APEX 4 (2014), APEX 5 (2017), and APEX 6(2022).
